Thomas A Peterman1, Daniel R Newman1, Lorene Maddox2, Karla Schmitt3, Stacy Shiver2. 1. Centers for Disease Control and Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Division of STD Prevention, Epidemiology and Surveillance Branch, Atlanta, GA. 2. Florida Department of Health, Division of Disease Control and Health Protection, Tallahassee, FL. 3. Florida State University, College of Nursing, Tallahassee, FL.
Abstract
OBJECTIVE: Multiple interventions have been shown to reduce the risk of HIV acquisition, including preexposure prophylaxis with antiretroviral medications, but high costs require targeting interventions to people at the highest risk. We identified the risk of HIV following a syphilis diagnosis for men in Florida. METHODS: We analyzed surveillance records of 13- to 59-year-old men in Florida who were reported as having syphilis from January 1, 2000, to December 31, 2009. We excluded men who had HIV infection reported before their syphilis diagnosis (and within 60 days after), then searched the database to see if the remaining men were reported as having HIV infection by December 31, 2011. RESULTS: Of the 9,512 men with syphilis we followed, 1,323 were subsequently diagnosed as having HIV infection 60-3,753 days after their syphilis diagnosis. The risk of a subsequent diagnosis of HIV infection was 3.6% in the first year after syphilis was diagnosed and reached 17.5% 10 years after a syphilis diagnosis. The risk of HIV was higher for non-Hispanic white men (3.4% per year) than for non-Hispanic black men (1.8% per year). The likelihood of developing HIV was slightly lower for men diagnosed with syphilis in 2000 and 2001 compared with subsequent years. Of men diagnosed with syphilis in 2003, 21.5% were reported as having a new HIV diagnosis by December 31, 2011. CONCLUSION: Men who acquire syphilis are at very high risk of HIV infection.
OBJECTIVE: Multiple interventions have been shown to reduce the risk of HIV acquisition, including preexposure prophylaxis with antiretroviral medications, but high costs require targeting interventions to people at the highest risk. We identified the risk of HIV following a syphilis diagnosis for men in Florida. METHODS: We analyzed surveillance records of 13- to 59-year-old men in Florida who were reported as having syphilis from January 1, 2000, to December 31, 2009. We excluded men who had HIV infection reported before their syphilis diagnosis (and within 60 days after), then searched the database to see if the remaining men were reported as having HIV infection by December 31, 2011. RESULTS: Of the 9,512 men with syphilis we followed, 1,323 were subsequently diagnosed as having HIV infection 60-3,753 days after their syphilis diagnosis. The risk of a subsequent diagnosis of HIV infection was 3.6% in the first year after syphilis was diagnosed and reached 17.5% 10 years after a syphilis diagnosis. The risk of HIV was higher for non-Hispanic white men (3.4% per year) than for non-Hispanic black men (1.8% per year). The likelihood of developing HIV was slightly lower for men diagnosed with syphilis in 2000 and 2001 compared with subsequent years. Of men diagnosed with syphilis in 2003, 21.5% were reported as having a new HIV diagnosis by December 31, 2011. CONCLUSION:Men who acquire syphilis are at very high risk of HIV infection.
Authors: Robert M Grant; Javier R Lama; Peter L Anderson; Vanessa McMahan; Albert Y Liu; Lorena Vargas; Pedro Goicochea; Martín Casapía; Juan Vicente Guanira-Carranza; Maria E Ramirez-Cardich; Orlando Montoya-Herrera; Telmo Fernández; Valdilea G Veloso; Susan P Buchbinder; Suwat Chariyalertsak; Mauro Schechter; Linda-Gail Bekker; Kenneth H Mayer; Esper Georges Kallás; K Rivet Amico; Kathleen Mulligan; Lane R Bushman; Robert J Hance; Carmela Ganoza; Patricia Defechereux; Brian Postle; Furong Wang; J Jeff McConnell; Jia-Hua Zheng; Jeanny Lee; James F Rooney; Howard S Jaffe; Ana I Martinez; David N Burns; David V Glidden Journal: N Engl J Med Date: 2010-11-23 Impact factor: 91.245
Authors: Melanie M Taylor; Kellie Hawkins; Anthony Gonzalez; Kate Buchacz; Getahun Aynalem; Lisa V Smith; Jeff Klausner; Scott Holmberg; Peter R Kerndt Journal: J Acquir Immune Defic Syndr Date: 2005-04-15 Impact factor: 3.731
Authors: Kate Buchacz; Jeffrey D Klausner; Peter R Kerndt; R Luke Shouse; Ida Onorato; Peter D McElroy; Joseph Schwendemann; Pradnya B Tambe; Michelle Allen; Frank Coye; Charlotte k Kent; Mahin N Park; Kellie Hawkins; Erika Samoff; John T Brooks Journal: J Acquir Immune Defic Syndr Date: 2008-02-01 Impact factor: 3.731
Authors: H Irene Hall; Ruiguang Song; Philip Rhodes; Joseph Prejean; Qian An; Lisa M Lee; John Karon; Ron Brookmeyer; Edward H Kaplan; Matthew T McKenna; Robert S Janssen Journal: JAMA Date: 2008-08-06 Impact factor: 56.272
Authors: Kyle T Bernstein; Julia L Marcus; Giuliano Nieri; Susan S Philip; Jeffrey D Klausner Journal: J Acquir Immune Defic Syndr Date: 2010-04-01 Impact factor: 3.731
Authors: Marta-Louise Ackers; Alan E Greenberg; Carol Y Lin; Bradford N Bartholow; Adrian Hirsch Goodman; Michael Longhi; Marc Gurwith Journal: PLoS One Date: 2012-04-18 Impact factor: 3.240
Authors: Matthew J Murphy; Brooke G Rogers; Laura C Chambers; Alexandra Zanowick-Marr; Drew Galipeau; Madeline Noh; Ty Scott; Siena C Napoleon; Jennifer Rose; Philip A Chan Journal: AIDS Patient Care STDS Date: 2022-08 Impact factor: 5.944
Authors: Ikenna Unigwe; Seonkyeong Yang; Hyun Jin Song; Wei-Hsuan Lo-Ciganic; Juan Hincapie-Castillo; Robert L Cook; Haesuk Park Journal: J Clin Med Date: 2021-12-24 Impact factor: 4.241